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The first aim of this study was to examine how low-intensity endurance exercise affects the 
regeneration process in rats with mechanical muscle damage. The rats were divided into three 
groups: sedentary, sedentary crush, crush trained. After the crush, to evaluate the regeneration 
process, rats were subjected to low-intensity endurance exercise by running on a motorized 
Rota-Rod for 5 v  days/week for 4 weeks at progressively increasing loads.  
At the end of the training period, the rats were sacrificed and the quadriceps muscle was 
collected for subsequent analysis by western blotting. 
The reduction of regeneration process was evaluated by examining the protein expression of 
connexin-39 (Cx39), a specific gene expressed during regeneration process of injured 
muscles. While Cx39 was not expressed in sedentary rats, it was markedly increased in 
sedentary crushed rats, because of active degeneration/regenerating process, and dropped to 
very low levels in exercised crushed rats, suggesting a reduction of muscle regeneration 
process. 
To evaluate the face of tissue regeneration compared to areas of necrosis, characteristics in the 
presence of damage muscle, histological sections were stained with hematoxylin-eosin. These 
sections have shown, with regard to the rats with crush trained a reduction of the face of tissue 
regeneration. 
The second aim of the study was to conduct an analysis of the proteomic profile of mouse 
models of Duchenne muscular dystrophy, in order to understand what were the molecular 
mechanisms underlying the process of muscle regeneration increased from training. For 
proteomic analysis mdx mice were divided into three groups: wt mice, mdx mice sedentary 
and trained mdx mice. 
The analysis of the proteomic profile  evidenced that, among the phenotypes examined 
proteins that show a significant change in the levels of expression, are proteins that regulate 
the mechanism of oxidative stress, characteristic of the fibers dystrophic. In particular, we 
have identified three proteins that show variations between the phenotypes mdx sedentary and 
mdx trained mice: the three isoforms of carbonic anhydrase and superoxide dismutase-c. 
SUMMARY 
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The expression levels of the Sod-c decrease in the quadriceps muscle of mdx sedentary and 
increase levels of CAH-3; in the quadriceps muscle of mdx trained there is an increase in the 
Sod-c, and simultaneously a decrease of the levels of the CAH-3. Such changes may lead to a 
decrease of the formation of free radicals and then ultimately to a decrease in oxidative stress 
and therefore to a reduction of tissue damage. 
This study has shown that specific low intensity endurance exercise induces a strong 
beneficial effect on the regeneration of damaged muscle and may have therapeutic value at 
least to decrease progression of muscular fibers necrosis.  
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INTRODUCTION 
 
             Skeletal muscle 
 
keletal muscle is composed of multinucleated long cylindrical cells, which contract in 
response to stimuli volunteers to allow the movement of the entire body or parts of it. 
These cells originate from mesodermal precursors, myoblasts, which during 
embryonic development combine to give rise to multinucleated syncytia phones known as 
myotubes that subsequently differentiate into contractile muscle fibers. Despite the nuclei 
present within the muscle fiber, being exited from the cell cycle in an irreversible manner, 
they are in a permanent postmitotic state, the adult skeletal muscle is a highly dynamic tissue 
capable of regeneration after damage induced by exercise, by 'immobilization or by 
mechanical trauma or chemical substances. In response to exogenous stimuli or biological 
factors, muscle is, in fact, able to adapt increasing its size and the amount of contractile 
proteins. This implies an increase in the size of the fibers and their consequent production of 
force. The muscle remodeling occurs throughout life, although at different rates according to 
the stages of development, and is due to a particular type of stem cells located between the 
basal lamina and the sarcolemma of each fiber muscle called "satellite cells". 
Discovered almost 50 years ago by Alex Mauro satellite cells were observed by him and 
described for the first time in the muscle fiber of frog. The cells were intimately associated 
with skeletal muscle fibers (MAURO, 1961) and positioned exactly between the membrane of 
the muscle fibers and the basal lamina.In adult muscle satellite cells are normally quiescent, 
but act as reserve cell population able to proliferate in response to any damage, thereby 
initiating the process of regeneration of skeletal muscle and giving rise to other satellite cells 
(Blaveri et al., 1999) . The study of satellite cells, until a short time ago identifiable only 
through accurate electron microscopy, is a result of very simplified following the discovery of 
the expression of particular protein factors from the aforementioned cells, but not by 
myonuclei in muscle fibers postmitotiche.Tra these factors: the M-cadherin cell adhesion 
molecule calcium - dependent, the C-met, the receptor for hepatocyte growth factor (HGF), 
nuclear factor miocitico (MNF) and Pax-7, transcription factor of type "paired box "(Hawke 
and Garry, 2001). Satellite cells appear on the edges of the muscle fibers in about seventeen 
days embryonic life, after they have formed the primary muscle fibers. Their origin is still not 
S 
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known, but it seems that they derive from the dorsal aorta (Seale and Rudnicki, 2000). At the 
time of birth account for about 32%, but have decreased with age until it reaches a level of 1-
5% in adults (Schultz and McCormick, 1994). The satellite cell activity is almost absent in 
adult skeletal muscle is not damaged and no myopathic (Decary et al., 1997), while satellite 
cells are activated as a result of muscle injury, when proliferate, differentiate into myoblasts 
fuse to form myotubes, which then differentiate into myofibers, or join the segments of the 
damaged muscle fibers to repair. 
 
Connexins and gap junctions in skeletal muscle  
The gap junctions (Figure) are specialized regions of membrane composed of aggregates of 
transmembrane channels that directly connect the cytoplasm of adjacent cells, and that allow 
the intercellular movement of ions, metabolites, and second messengers (Bruzzone et al., 
1996b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The passage of ions and small molecules through gap junctions, as second messengers 
(cAMP, IP3), produces an electrical coupling and metabolic cell. Each intercellular channel is 
formed by the junction of two hemichannels, or connexons, formed by assembling of 
hexameric protein subunits, called connexins and characterized by two distinct properties, the 
ionic conductance and permeability. Each connection can contain either a single type of 
connexins (homomeric), or different types of connexins (heteromeric); also intercellular each 
 
Fig.1: Gap Junctions structure 
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channel can be defined homotypic or 
heterotypic (Bruzzone et al., 1996a), 
depending from the opposition of 
connexons that have the same or 
different molecular composition. 
These intercellular channels are not 
always open, but is governed by 
several factors such as pH, the 
membrane potential or different 
pharmacological agents. Each 
connexin consists of 4 α-helical 
transmembrane domains, two 
extracellular loops, a cytoplasmic 
loop, an amino terminal cytoplasmic domain, and a carboxy terminal. 
 
When two cells are placed close together, the connections from one cell can stick with their 
counterparts in the neighboring cell and thus form a gap junction channel. According to the 
cell type and the connexins expressed, the connexons can function as hemichannels, providing 
a pathway for the signaling tansmembrana, while the gap junction channels will be able to 
provide a pathway for direct communication between the cytoplasms of adjacent cells. This 
type of intercellular communication permits coordinated cellular activities, critical function 
for homeostasis of the organ during development and adult life of multicellular organisms.  
The gap junctions participate in the regulation of various functions, including the contraction 
of the cardiac muscle and smooth muscle (De Mello, 1994; Miller et al., 1989; Page and 
Shibata, 1981; Spray and Burt, 1990), the transmission of neural signals at synapses 
electrotonic (Auerbach and Bennett, 1969; Bennett and Verselis, 1992; FURSHPAN and 
POTTER, 1959; Sotelo and Llinas, 1972), and cooperation in the development of metabolic 
and vascular organs. The permeability of intercellular channels to second messengers may 
also regulate the secretion by the exocrine pancreas is that endocrine (Bruzzone and Meda, 
1988; Serre-Beinier et al., 2000) and plays a critical role in the formation during development 
(Caveney, 1985; Guthrie and Gilula, 1989). 
The connexin gene family includes 20 members in mice and 21 members in the human 
genome. The connexins are commonly named according to their molecular weight (for 
example, Cx43 has a mobility of 43kDa), and their genes have been classified into 4-5 groups 
Fig.2: The figure shows the structure and functioning of 
connexons. 
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(according to the sequence homology). Each has a different pattern of connexin expression 
and different regulatory properties. Nine of these connexins are expressed in the brain, but 
only the connexins Cx36 (Condorelli et al., 2000) and CX45 are expressed in neurons. These 
two connexins are widely expressed during embryogenesis and their expression persists even 
during the post-natal life, in a specific region of the central nervous system. After birth the 
Cx36 remains expressed in many areas of the brain and in particular in the olfactory bulb 
(Belluardo et al., 2000). The CX45, however, is highly expressed during embryogenesis and 
up to 2 weeks after birth in almost all regions of the brain. Following its expression is limited 
to the thalamus, the CA3 region of the hippocampus and cerebellum (Maxeiner et al., 2003). 
The other connexins present in the nervous system are exclusively expressed in glial cells 
(Condorelli et al., 2003). 
The gap junctions are found in almost all tissues of mammals with the exception of adult 
skeletal muscle, while they are present in embryonic development (Balogh et al., 1993; 
Schmalbruch, 1982). This characteristic is due to an intrinsic property of skeletal muscle. The 
muscle fibers, in fact, must be electrically isolated from each other to avoid the spread of the 
current depolarization. Contrary to adult muscle tissue was observed that the myogenic 
progenitor cells are capable of adhering and merge in a highly coordinated and form gap 
junctions, suggesting a role of these channels in early muscle differentiation (Constantin and 
Cronier, 2000). The gap junctions, in fact, have been finding in skeletal muscle embryonic 
and neonatal chicken, mice and rats. The importance of intercellular communication mediated 
by gap junctions in myogenesis is further supported by a study of (Proulx et al., 1997) in 
which it was shown that after application of pharmacological blockers of gap junctions, 
myoblasts do not express myogenin or MRF4, both markers of terminal differentiation. 
Electron microscopy studies have also demonstrated the presence of gap junctions between 
myoblasts and between myoblasts and myotubes during embryonic development. These 
connexins are: Cx39, Cx40, Cx43 and CX45 (Belluardo et al., 2005; von et al., 2004). In 
myoblasts, the expression of Cx43 is predominant and is a prerequisite for fusion (Squecco et 
al., 2006).It is expressed initially in the embryonic stage of 11 days in the Somita 
dermomiotomo. The Cx43 is expressed in many cell clusters and their expression varies 
according to the type of muscle. At the embryonic stage of 18 days, when the miotubo is fully 
formed, the expression of connexin 43 is restricted to cells spread along the newly formed 
myotubes. The CX45, instead, is widely expressed in many cells of the skeletal muscles in the 
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early stages of myogenesis, then its expression decreases after birth and is limited to cells 
along the myotubes, probably satellite cells. 
The different times of the expression of the connexon is important for the proper 
differentiation of skeletal muscle, for example, the over-expression of Cx43 in cultured 
myotubes of mouse, under control of a viral constitutive promoter active, leads to a significant 
cell death during differentiation . The first signal of mRNA for Cx39 was instead observed to 
E12, at the level of myotomes. At the embryonic stage of 16 days, the Cx39 mRNA is 
expressed in all skeletal muscles during development, but around the 20th day, the expression 
of Cx39 in several muscles decreases and disappears within the first week of post-natal life 
(Belluardo et al., 2005), suggesting that this connexin is not involved in the process of post-
natal growth of muscle mass. It was also shown that this connexin is expressed in adult 
skeletal muscle in regeneration phase after damage from trauma (Belluardo et al., 2005). 
A recent study has also shown that in mice deficient for the Cx39, skeletal muscles is 
regularly and myogenesis, as the regeneration process, was not affected . 
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Fig.3.: Muscle structure 
 
Muscle Regeneration 
One of the most important processes that have been conserved during the evolution is the 
tissue regeneration, in wich interactions between infiltrating inflammatory cells and resident 
cells must be finely coordinated if homeostasis and functionally are to be restored. If 
something disrupted  these interactions the result would be the failure of regeneration, and in 
the worst case this would lead to the death of the individual.(Soehnlein and Lindbom, 2010)  
The skeletal muscle, is the most abundant tissue of the body, Skeletal muscles consist of 
muscle cells, networks of nerves and blood vessels, and connective tissues that connect 
individual fibers into bundles, which form the muscle. The epimysium is the fibrous outer 
layer that surrounds the complete muscle, the perimysium surrounds the bundles of 
myofibers, and the endomysium (also called the basement membrane) surrounds individual 
myofibers (Huard et al., 2002). Myofibers are the basic structural elements of skeletal muscle 
and are composed of multiple fused myoblasts. Newly formed multinucleated fibers exhibit 
central nucleation, and once the nuclei move to a subsarcolemmal position they are called 
myofibers (Huard et al., 2002). The interior of a myofiber contains the sarcomeres, which are 
the basic functional units of skeletal muscle. The sarcomere consists of thick myosin 
filaments that interdigitate with thin actin filaments and is specialized to respond to 
neuromuscular signals. In response to these signals, the cell depolarizes and this leads to the 
release of calcium from the sarcoplasmatic reticulum. 
It’s important for a lots of 
physiological processes, so a loss of 
muscle functionality in acute or 
chronic conditions results in 
diminished mobility and strength, in 
addition to metabolic disorders, which 
can have potentiality lethal 
consequeces.  
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It may appen that a persistent myofibre degeneration and an inflammatory infiltration, as it 
occurs in DMD or when the extracellular matrix deposition is excessive, may bring to the 
substitution of the normal muscle architecture by fibrotic tissue.(Serrano and Munoz-
Canoves, 2010) 
Depending on the severity of the damage suffered by skeletal muscle depends on its own 
healing. However the healing process consists of three phases: 
 
 The destruction phase 
 The repair phase 
 The remodeling phase. (Charge and Rudnicki, 2004; Huard et al., 2002). 
 The destruction phase is characterized by necrosis, hematoma formation, and the influx of 
inflammatory cells. In the repair phase, the necrotic debris is phagocytosed, and regeneration 
of myofibers occur through the action of SCs ( satellite stem cells). (Zammit et al., 2006b). At 
first, the SCs  expressing Pax7 migrate to the site of injury, up-regulate the myogenic 
regulatory factors ( MRFs) MyoD and Myf5, and become proliferative. From this moment on 
the SCs are also known as myoblasts. Subsequent differentiation of myoblasts is marked by 
the down-regulation of Pax7 and the up-regulation of the MRFs Mrf4 and Miogenin. 
(Cornelison and Wold, 1997; Yablonka-Reuveni and Rivera, 1994).Lastly, these 
differentiated myoblasts form multinucleated myofibers (hyperplasia) or fuse to damaged 
myofibers (hypertrophy) for muscle regeneration.(Charge and Rudnicki, 2004; Hawke and 
Garry, 2001). 
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The skeletal muscle regeneration is a process regulated by a lots of factors, such as SCs, 
cytokines, growth factors, and neurotrophic factors that  play a prominent role. 
 
The satellite cell niche 
The most common definition for a stem celle niche is “a specific location in a tissue where 
stem cells can reside for an indefinite period of time and produce progeny cells with self 
renewing”. (Ohlstein et al., 2004). In the SCs niche a lots of factors influenced the behavior of 
SCs, such as: 
 Structural elements (basal membrane and myofibers); 
 Products secreted by local cells, such as the interstitial cells, microvasculature, 
neuromuscular junction, immune cells. (Gopinath and Rando, 2008). 
The SC niche is surrounded by the basal membrane (BM) and adjacent differentiated 
myofiber. Also the microvasculature seems to play a role: in humans and mice, respectively 
68% and 82% of the SCs are located  5µm from neighboring capillaries or vascular 
endothelial cells (EC).(Christov et al., 2007). Furthemore there is a correlation between the 
number of capillaries per muscle fiber and the number of SCs (Christov et al., 2007). This 
strongly suggests a correlation between SC and ECs during myogenesis. 
 
 
 Fig.4. : The figure shows the activation of the 
  
Regulation of skeletal muscle regeneration 
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Moreover, recent studies showed that macrophages, which are attracted upon injury, play a 
crucial role in skeletal muscle regeneration. In vivo macrophage suppression leads to 
incomplete skeletal muscle regeneration.(Segawa et al., 2008). Malerba (Malerba et al., 2009) 
and Segawa (Segawa et al., 2008), suggest that macrophage play an important role in that they 
act according  two mechanism:  
1. Macrophage can secret soluble factors affecting SCs; 
2. Macrophage can interact with SCs by cell-cell contact, ant thereby protect them from 
apoptosis. (Chazaud et al., 2003) 
Depending on their activity, macrophages play a dual role : pro-inflammatory macrophages 
that induce myogenic precursor cell proliferation; anti-inflammatory macrophages that induce 
differentiation and fusion of these cells.(Villalta et al., 2009). 
The basis for the regulation of SC behavior is the attachment within their specific niche, wich 
is established trough cell-BM and cell-cell interactions. The basal side of the SCs expresses 
integrin α7β1, which links the cytoskeleton with laminin in the BM (Burkin et al., 2005)  . 
The apical side expresses M-cadherin that attaches the SC to the adjacent myofiber 
(Cornelison and Wold, 1997; Kuang et al., 2008).Both attachment sites are essential for signal 
transduction betweenthe SC and the two flanking structures (Cornelison and Wold, 1997). 
Furthermore it has been suggested that M-cadherin plays a significant role in theattachment 
and fusion of myoblasts to form new and regenerate damaged myotubes. This is supported by 
a significant increase of M-cadherin in activatedSCs during skeletal muscle regeneration 
(Irintchev et al., 1994). 
 
Growth Factor 
Growth factor are crucial in SC  regulation. Due to growth factor-activated intracellular 
signaling pathways ( insulin growth factor-1, IGF-1) (Charge and Rudnicki, 2004; Philippou 
et al., 2007), both controlled up and down regulation of muscle specific genes occur.(Hawke 
and Garry, 2001). Immune cells and muscle cells after injury secreted a lots of growth factor, 
furthermore the vasculature, the SCs themselves and motor neurons are also responsible for 
growth factor production. There are also a group of growth factor that are defined “indirect” 
in that they are stored at the ECM (extracellular matrix) by binding proteoglycans e then 
they’re released from the ECM after skeletal muscle injury. To make this SCs have to 
increase the release of matrix metalloproteinases -2 and-9 after injury. These MMPs are 
involved in ECM degradation that liberates growth factors and cytokines. So, SCs can 
activate themselves indirectly .Furthermore, MMPs are involved in myoblast migration during 
Dott.ssa Rossella Prestigiacomo Pag. 15 
 
regeneration. (El et al., 2000; Kherif et al., 1999; Torrente et al., 2000). All these growth factors 
secreted together with that there’re released from ECM, attract, activate, and induce 
differentiation the SCs. (Grefte et al., 2007; Huard et al., 2002). Between growth factors that 
promote the activation and subsequent differentiation of SCs we find:  
 
 HGF; 
 FGF-2 and -6; 
 Vascular endothelial growth factor (VEGF); 
 Platelet derived factor- I ( SDF-I); 
 IGF -1 and -2. 
 
This factor together play a major role in myogenic  proliferation and differentiation. 
The major inhibitory factors in skeletal muscle regeneration are myostatin, transforming 
growth factor –α and β1 (TGF α and β1), and bone morphogenetic proteins ( BMPs), wich are 
all members of the TGF – β superfamily.(Gordon and Blobe, 2008) 
 
The family contains many regulatory 
factors, wich depending on the tissue, affect cellular behavior. Among these factors we find 
Fig.5: The figure shows the differentiation of satellite cells 
into myotubes and the different factors expressed during 
the differentiation of SCs 
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Fig.6: The figure shows other cells that according 
to the microenviroment have myogenic capacity 
myostatin. This factor is expressed in SCs and myoblasts. Myostatin release results in a down 
regulation of Pax3 and Myf5, and prevents the expression of MyoD. (Amthor et al., 2002). 
Myostatin may maintain SC quiescence and repress self-renewal through the induction of 
p21cip (McCroskery et al., 2003; Shi and Garry, 2006), wich is a universal inhibitor of cyclin-
dependent protein kinase and thus a cell cycle inhibitor. (Jaumot et al., 1997) 
 
Stem cells in skeletal muscle regeneration. 
In addition to SCs  many other  stem cells show, at the level of skeletal muscle, myogenic 
capacity depending on the environment in which they are located.(Charge and Rudnicki, 
2004). They can be divided into: 
 
 Mesangyoblasts (vessel associated stem cells); 
 Side population cells (SP cells); 
 Muscle derived stem cells (MDSCs); 
 Perycites; 
 Cd 133+ stem cells. (Figure.) 
 
Mesangyoblasts are vessel associated stem cells derived from the embryonic dorsal aorta and 
are able to differentiate into several mesodermal cell types including skeletal muscle. (Cossu 
and Bianco, 2003; Minasi et al., 2002). 
The heterogeneous muscle SP cells, 
are a rare, poorlydefined population 
in skeletal muscle, but they have the 
potential to give rise to both myocytes 
and SCs after IM injection (Asakura 
et al., 2002; Uezumi et al., 2006). 
Muscle SP cells are still present in 
Pax7_/_ mice, which exhibit a severe 
deficiency in SCs (Asakura et al., 
2002). 
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MDSCs are a population of early myogenic progenitor cells which have, in contrast to SCs, 
multi-lineage potential.Pericytes are localized underneath the basal lamina of the 
microvasculature and interdigitate with the endothelial cells. 
They give stability to the microvessels and also regulate blood flow and permeability of the 
vessels (Armulik et al., 2005). It has been suggested that pericytes are developmentally 
derived from mesoangioblasts (Cossu and Bianco, 2003; Dellavalle et al., 2007; Minasi et al., 
2002).They become myogenic in vitro when differentiation is induced and contribute to 
muscle regeneration in dystrophic mice after intra-arterial injection (Boldrin and Morgan, 
2007; Dellavalle et al., 2007). Unlike SCs, pericyte-derived myogenic cells express myogenic 
markers only in differentiated myotubes. 
CD133+ cells circulate in the blood stream and they are able to differentiate, in vitro, into 
endothelial, hematopoietic, and muscle cell types (Torrente et al., 2004). CD133þ cells 
express adhesion molecules such as very late antigen-4 (VLA-4), which renders them capable 
to migrate through blood vessel walls. 
The only relevant non muscle-derived stem cell, the hematopoietic stem cell (HSC), is also 
the most important multipotent stem cell participating in skeletal muscle regeneration after the 
SC (Charge and Rudnicki, 2004; Corbel et al., 2003; Ferrari et al., 1998). Among all these 
cells, the first cell type that participate to muscle regeneration is the satellite cells. Therefore 
these cells are a good candidate for the therapy of injured or desease muscle.(Zammit et al., 
2006a). 
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Duchenne muscular dystrophy (DMD) 
Duchenne muscular dystrophy (DMD), is a genetic condition affecting predominantly boys 
that is characterized by fatal muscle weakness. While there is no cure, recent therapeutic 
advances have extended the lifespan of those with DMD considerably. 
This pathology and the hologue condition in the mdx mice model, are caused by X-chromose 
gene mutations that lead to the absence of the protein dystrophin(Grounds et al., 2008; 
Hoffman and Dressman, 2001).Dystrophin is a subsarcolemmal component of a multi-
molecular network ( the dystrophin-glycoprotein complex, DGC) that ensures a physical 
linkage between the intracellular cytoskeleton and the extracellular matrix.  The widely 
accepted theory is that dystrophin provides mechanical stability to myofibre during 
contraction. The absence of dystrophin triggers a complex and still unclear sequence of events 
that eventually leads to progressive myofibre degeneration, failing regeneration and fibrosis, 
thus resulting in muscle weakness and wasting.(Hoffman and Dressman, 2001).  
This disease is caused by a mutation in the gene located in band Xp21 of the X chromosome 
that encodes a 427-kDa cytoskeletal protein called dystrophin, a protein essential for the 
maintenance of the integrity of cardiac and skeletal muscle cells. (Lovering et al., 2005).  
The dystrophin gene spans approximately 2.5 Mb and is composed of 79 exons. In skeletal 
muscle, dystrophin is located on the cytoplasmic side of the sarcolemma and it is associated 
with glycoproteins and forms the dystrophin-glycoprotein complex (DGC). Structurally, 
dystrophin can be divided into four distinct domains: an amino-terminal domain, a large 
central rod domain, a cysteine-rich domain, and a carboxiyl-terminal domain. Other proteins 
of the DGC include dystroglycans (α e β), sarcoglycans (α,β,γ e δ), sarcospan, dystrobrevin 
(α), and syntrophins (α1, e β1).(Durbeej and Campbell, 2002) 
 The interactions of  DGC proteins mediate the binding of the cytoskeleton to laminin-2 in the 
basal lamina of the extracellular matrix. The lack of the dystrophin protein interrupts the link 
between the extracellular matrix and the fiber cytoskeleton, causing sarcolemmal instability ( 
muscle fibers lose their stability) and disorganization of DGC components during cycles of 
muscle contraction and relaxation. These events, in turn, lead to the exacerbated inflow of 
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calcium ions, activation of 
calcium-dependent 
endogenous proteases, 
inhibition of mitochondrial 
activity, and muscle fiber 
hyperconcontraction. A 
process of muscle 
regeneration then starts 
trough the activation of 
satellite cells, followed by 
the formation and maturing 
of myotubes in muscle 
fibers.  
Various key events in the 
process have been 
identified, and many of 
them are related to muscle activity, such as recurrent states of ischemia due to impaired nitric-
oxide induced vasodilatation, alterations in calcium homeostasis via mechano-sensitive 
pathways, an early and self- sustained inflammatory response paralleled by oxidative stress, 
and an impaired balance between protein synthesis and degradation.(Rando et al., 1998) 
 
Fibrosis in DMD 
Generally, fibrosis is referred to as replacement of normal tissue with scar tissue. This means 
that fibrous connective tissue is the result of reactive or reparative process. 
As seen above, the genetic cause of DMD is an x-chromosomal mutation of the dystrophin 
gene. Dystrophin mechanically stabilizes myofibres by linking the cytoskeleton to the basal 
lamina through the dystroglycan complex; a dysfunction or a lack in the normal function of 
the dystrophin protein dues to an instability of muscle fibre membranes. As a result, the cells 
are less resistant to mechanical shear and prone to excess influx of electrolytes such as 
calcium and sodium. 
This influx of electrolites produce an increase of intracellular sodium that leads to the ATP  
depletion, because the Na+/K+ pumps need to operate at full capacity. Water molecules 
 
Fig.7: Interactions of DGC proteins mediate the binding of the 
cytoskeleton to laminin-2 in the basal lamina of the 
extracellular matrix 
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accompanying sodium produce cellular oedema. This gradient promotes calcium overload. 
Resulting in mithocondrial uncoupling and the production of reactive oxygen species (ROS) 
such as oxygen ions and peroxides. Downstream the result is an accumulation of 
inflammatory molecules such as cytokines. 
Various stimuli including chemotaxis and mechanicals too, initiate the production of fibrous 
tissue. It is composed of extracellular fluid containing fibronectin, glycosaminoglycans and 
proteoglycans. These molecules can bind to water and therby influence the mechanic 
properties of the tissue.  
Chronic tissue contracture is generated by a combination of cellular contraction and collagen 
fibre remodeling. Myofibroblasts actively contract via a calcium-dependent phosphorylation 
of the myosin light chain. Fibrocytes and myofibrobalsts usually are present for a time during 
tissue repair, such as  in wound healing. In the case of DMD, activation of myofibrobalsts is 
persistent due to constant myofibre breakdown. This mechanism results in a altered 
production of ECM; the provisional ECM in fibrosis is different in composition from the 
ECM of normal tissue. In the early stage of fibrosis, the relative content of fibronectin and 
hyaluronan is higher than  to non- injured tissue. This microenviroment creates a very 
hydrated matrix and facilitates cell migration.(Klingler et al., 2012) 
 
Therapeutic approaches to muscular dystrophy 
Muscular dystrophies are a group of heterogeneous diseases that primarily affect striated 
muscles throughout the body. Many of these myopathies are caused by mutations in genes 
that encode for structural proteins that link the cytoskeleton of muscle fi bers to the 
extracellular matrix. The absence of functional proteins results in destabilization of the muscle 
membrane, increased muscle fragility and degeneration, and progressive muscle wasting, all 
of which compromise patients’ mobility and, in the severe disease forms (Emery, 2002) such 
as Duchenne muscular dystrophy (DMD1), lead to death. The course of the disease although it 
is progressive, varies from individual to individual. The diagnostic process can be initiated 
following a hit, sometimes random, increased creatine kinase (CK) in the blood, an enzyme 
that phosphorylates creatine and nonspecific marker of muscle damage. The diagnosis is 
based on two types of assessments: muscle biopsy and DNA analysis. Muscle biopsy can 
determine the histopathological often typical of a dystrophic process with degeneration, 
regeneration fibrale and fibro-fatty replacement and is the fabric on which to study the 
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presence / absence of dystrophin by immunohistochemical and biochemical analysis. Affected 
individuals can be diagnosed at birth on the basis of elevated serum levels of muscle enzymes. 
They exhibit muscle weakness by age 5, lose independent ambulation, and succumb to 
respiratory failure or cardiomyopathy in their late teens or twenties (Muntoni, 2003; Tyler, 
2003). 
In the absence of a cure for the disease, there are various therapeutic strategies which aim is to 
act on the secondary symptoms of the DMD for the purpose of limiting the progression and 
improve quality of life. These therapeutic interventions include: 
 
 The use of steroids such as oxandrolone and prednisonehelps to increase protein 
synthesis and thus conserve muscle mass (Tidball and Wehling-Henricks, 2004; Zhao 
and Hoffman, 2004).; 
 Proteolytic systems are targeted for decresing proteolysis in dystrophic muscle and 
slowing loss of muscle mass; 
 Increased infl ux of calcium may be an option for increasing the activity of a calcium-
dependent protease, calpain,in dystrophic muscle; 
 Because overexpression of calpastatin, a natural inhibitor of calpain, reduces necrosis 
in mdx muscle (Spencer and Mellgren, 2002; Tidball and Wehling-Henricks, 2004), 
investigators have used β2-adrenergic agonists and pharmacophore to inhibit calpain 
activity (Burdi et al., 2006; Spencer and Mellgren, 2002). The application of 
immunosuppressants such as glucocorticoids and anti-TNFα antibody reduces the 
inflamm amatory responses associated with the disease and delays pathology (Grounds 
and Torrisi, 2004; Manzur et al., 2008) 
  
However, despite the utility of these therapeutic treatments, side effects are encountered both 
on animal models and humans; therefore the use of these therapeutic interventions has been 
limited. The hope for the future, to correct the genetic defect present in DMD is that to 
introduce a functional gene for dystrophin in the muscles of patients with DMD. But the most 
important obstacle is represented by the huge size of the dystrophy gene. The normal gene 
replacement, therefore, is not presented as a possible approach and recently some studies have 
proposed alternative strategies, including the exon skipping. The skipping of specific exons 
aims to restore the reading frame of the dystrophin gene with the production of a protein 
internal missing but essentially functional, as is observed in the cases of Becker muscular 
dystrophy (Cossu, et al., 2007). 
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Has been  also investigated pharmacological basis of a therapy that involves the up-regulation 
of the protein utrophin. This protein is an orthologue of dystrophin protein. Proof of principles 
studies in mdx mice ( the animal model that is usually used to study DMD), have established 
that elevation of utrophin levels in dystrophic muscle fibers can restore sarcolemmal 
expression of the dystrophin associated complex (DAPC) members and alleviate the 
dystrophic  pathology. 
Another therapeutic strategy involves the use of stem cells. The stem cell therapy in an 
attractive method to treat musculardystrophy because only a small number of cells, together 
with a stimulatory signal for expansion, are required to obtain a therapeutic effect (Price et al., 
2006). The clinical relevancecandidate stem cell population must be easily extracted, 
mustremain capable of efficient myogenic conversion, and when transplanted must integrate 
into the muscles allowing the functional correction of the dystrophic phenotype.(Farini et al., 
2009) 
These results, however, collide with a major obstacle for the development of a cell therapy in 
humans: the low efficiency of integration of the stem cells in damaged muscle. The skeletal 
muscle is in fact the most abundant tissue in humans, complicating the extensive spreading of 
the stem cells to the entire fabric. Furthermore muscle degeneration associated with muscular 
dystrophy is followed by a sort of scarring which reduces the blood supply to the muscle. A 
new study shows in fact that the induction of revascularization of muscle tissue can be a 
strategy to overcome this obstacle and be able to adopt the therapy MABs ( mesangyoblasts 
therapy) with all patients (Gargioli et al., 2008). 
Other therapeutic strategies include the development of specific programs of muscle exercise 
using as experimental animal models dystrophic mice. 
The most widely used laboratory animal model for this type of experiments as it reflects the 
histopathology of Duchenne muscular dystrophy is the mdx mouse C57Bl/10ScSn (Bulfield 
et al., 1984). Mechanical function in mdx mice is not compromised and the muscle pathology 
is moderate and is more evident between the second and eighth week of life, a period 
characterized by the presence of necrotic foci, small areas of regeneration and a high level of 
plasma concentration of creatine kinase. Using different exercise regimens in an attempt to 
improve the function of the muscle showed that while an exercise excessive or improper use 
may cause further damage in the muscle doing worsen the condition (Brussee et al., 1997; 
Okano et al., 2005), an exercise in low intensity may make improvements to the muscle 
pathological (Hayes et al., 1993; Hayes and Williams, 1996; Hayes and Williams, 1998). The 
beneficial effects of regular exercise and low intensity have been reported after workout on 
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freewheel (Carter et al., 1995; Hayes and Williams, 1996), swimming and exercise of 
"endurance" to low intensity (Hayes and Williams, 1998). 
 
Mdx mice as a model for the study of Duchenne muscular dystrophy 
The mdx (X chromosome-linked muscular dystrophy) mouse is an experimental model 
widely used for the study of DMD, which is derived from a spontaneous mutation identified 
in theC57BL/10-ScSn mouse line. Like dystrophic humans, these animals carry a genetic 
mutation that causes the lack of dystrophin anan intense inflammatory process in muscles. 
However, mdx mice present efficient muscle regeneration and reduced fibrosis. For their 
characteristics mdx mice were used for the study of Duchenne muscular dystrophy and for the 
testing of biomedical techniques that reduce the damage of the fibers. In this context mdx 
mice, have been used to assay the effects of different exercise programmes on the  function 
and morphology of dystrophic muscle. 
 
Recovery of Damaged Skeletal Muscle in mdx Mice through Low-intensity Endurance 
Exercise. 
 
The lack of dystrophin in mdx mice leads to cycles of muscle degeneration and regeneration 
processes. Various strategies have been proposed in order to reduce the muscle-wasting 
component of muscular dystrophy, including implementation of an exercise programme.  
In a previous work conducted in our laboratory, (M. Frinchi, F. Macaluso, A. Licciardi  , V. 
Perciavalle  , M. Coco  , N. Belluardo  , G. Morici  G. Mudò),  it was demonstrated that an 
exercise of low-intensity  endurance produces beneficial effects in dystrophic muscle of mdx 
mice. Moreover, in the same work, it was evaluated and quantified for the first time the 
regeneration process in the dystrophic muscle of sedentary and exercised mdx mice by 
monitoring the expression of connexin 39 (Cx39), a specific gene involved in skeletal muscle 
regeneration process. 
The connexins (Cxs) are a multi gene family with at least 21 members in the human genome 
involved in gap junction channels formation in adjacent cell membranes by the docking of 2 
hemichannels (connexons), each consisting of  6 Cxs subunits. And our research group has 
cloned the gene for connexin 39 by demonstrating that it is expressed only in muscular tissue 
and selectively expressed during embryonic skeletal muscle development, absent in the adult 
muscle and expressed again during the process of muscle regeneration.(Belluardo et al., 
2005). From the study conducted in our laboratory, it was demonstrated that in muscle of mdx 
mice, endurance exercise produce beneficial effects, leading to remarkable recovery of 
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damaged muscle. These findings were supported by the results of the analysis and evaluation 
by histomorphological wb levels of cx39. 
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AIMS 
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First aim 
Effects of a low-intensity endurance exercise on skeletal muscle of rats with muscle injury 
from mechanical trauma 
 
In muscle biopsies from patients with Duchenne Muscular Dystrophy is possible to observe 
the areas of necrosis or degeneration of muscle fibers, often observed in clusters surrounded 
by macrophages and lymphocytes, and areas with small immature fibers with central nuclei 
which represent areas of regeneration, resulting in a balance between necrotic and 
regenerative processes (Brunelli et al., 2007; Grounds and Torrisi, 2004; Hodgetts et al., 
2006; Radley et al., 2007; Spencer and Mellgren, 2002). 
As described in the introduction, several strategies have been proposed in an attempt to reduce 
muscle degeneration characteristic of the disease, (Odom et al., 2007) (Carter et al., 1995; 
Hayes and Williams, 1996) (Hayes and Williams, 1998) and in the present study we wanted 
to study as an exercise in "endurance" low intensity, could facilitate the process of muscle 
regeneration in rats with injury mechanical trauma.. The work was devoted to the study of the 
process of muscle regeneration in rats that have suffered mechanical damage to the muscles 
after training. 
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Second Aim 
Rating proteomic pattern of protein expression in wild type mice, mdx sedentary 
mdx trained mice to identify some important proteins involved in skeletal muscle 
regeneration. 
Individual skeletal muscle protein are difficult to isolate and analyse biochemically due to the 
rigid structure of muscle fibers and the high density of contractile proteins and intracellular 
membrane systems. 
Because of  the high frequency of genetic muscle disordes there is considerable interest in 
studying protein expression and protein- protein interactions in normal versus diseased 
skeletal muscles. Often the identification of the primary genetic abnormality and the 
elucidation of secondary changes may not lead to a comprehensive understanding of the 
cellular downstream events that render muscle fibres more susceptible to necrosis. In 
conjunctions with findings from gene expression profiling studies, proteomics can be used to 
study how specific mutation can perturb the global protein expression pattern in 
muscle.(Doran et al., 2006) 
Into the possible therapeutic approaches, a much debated about the role of exercise in the 
progression of Duchenne muscular dystrophy. Although in the literature are present 
conflicting data, the study conducted in our laboratory directed by Prof.re Belluardo, has 
shown that aerobic exercise of short duration and low intensity plays a role in slowing the 
progressive muscle degeneration that is characteristic of this pathology, and appears to 
facilitate the formation of new muscle fibers. In fact, subjecting the mdx mice to a workout of 
short duration and low intensity and comparing the histological sections of quadriceps 
obtained from mdx trainede mice, from mdx sedentary mice and from wild type mice, there 
was a substantial decrease of the areas of necrosis, in especially after 30 days of training and 
with a very high significance. So we wondered what were the molecular causes of these 
beneficial effects due to training in mdx mice, and such variations could exist in the pattern of 
protein expression in dystrophic muscle tissue subjected and not subjected to an exercise in 
endurance. 
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Materials and Methods 
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Animals 
For the following study were used adult male Wistar rats (350 g bw) adult male mice and 
wild-type (C57BL/10ScSn from Harlan Italy). The animals were kept in a temperature (24 ± 2 
° C) and humidity (60%) and controlled with a period of alternating light-dark period of 12 h, 
with food and water ad libitum. All experiments were conducted following the guidelines of 
national (DL no. 116, GU, suppl. 40, February 18, 1992), the international laws and policies 
(European Economic Community Council Directive 86/609, OJ L 358, 1 , December 12, 
1987, National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals, 
NIH Publication no. 80-23, 1985 and Guidelines for the Use of Animals in Biomedical 
Research, Thromb Haemost 58: 1078 - 1084, 1987) and in accordance with the approval of 
the ethics committee of national and regional health surveillance. 
 
Animal model for the study of muscle regeneration following damage 
To analyze the process of tissue regeneration was performed a lesion at the level of the 
quadriceps and gastrocnemius muscles of rats. The animals were anesthetized prior and after 
skin incision and gastrocnemius muscle was discovered and mechanically compressed in the 
central area with a hemostat for 3s. Immediately after the parts have been saturated resected. 
The animals were sacrificed by an overdose of anesthesia in groups of three at different days 
after injury. The dissected muscle was frozen in cold isopentane, and stored at -70 ° C 
 
Training protocol 
Both wistar rats with muscle injury were divided randomly to the group of sedentary (SD) or 
trained (EX). In a very similar approach to be deficient rats muscle injury that wild type mice 
were assigned to the group of sedentary (SD) or that of trained (or Wt-EX-EX).  
 Regarding rats also have undergone a pre-training of 9 days to speed and increasing time in 
order to accustom to the movement. On the ninth day of training was carried out at the level 
of the lesion and quadriceps and gastrocnemius muscle was taken up training for 7 
consecutive days. 24 hours after the end of the last training session the rats were sacrificed 
with an overdose of anesthesia. 
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Western Blotting 
Each experimental group of animals was sacrificed with an overdose of anesthetic. The 
gastrocnemius muscle was taken with the aid of the stereomicroscope , frozen in isopentane 
and stored at -70 ° C. From these muscles were taken cryosections of 60μm and used for the 
assay of the levels of connexin 39 by western blotting. The muscle samples were 
homogenized in a cold buffer containing 50 mM Tris- HCL pH 7.4 , 150 mM NaCl , 1 % 
triton , 0.1 % SDS , H2O and a cocktail of protease inhibitors ( P8340 , Sigma -Aldrich Srl , 
Milan, Italy ) . The homogenate was left on ice for 30 minutes and then centrifuged at 13,000 
rpm for 30 minutes at 4 ° C. The supernatants were stored at -20 ° C and aliquots were used 
for protein determination using the Lowry method ( LOWRY et al , 1951). The samples with 
30 µg of protein a marker for the molecular weights ( 161-0375 , Bio -Rad Laboratories Srl , 
Segrate (MI ) , Italy) , were run on 8 % polyacrylamide gel at 100 V and transferred 
electrophoretically nitrocellulose membrane ( Hybond -C- extra , GE Healthcare, formerly 
Amersham, Europe GmbH Branch - Italian , Milan, Italy ) . After 1 h of incubation in 5% 
nonfat milk , the membrane was incubated overnight at +4 ° C with the polyclonal rabbit anti- 
Cx39 at a dilution of 1:1000 ( N-20 sc -546 , Santa Cruz Biotechnology , CA , USA). After 
washing the membrane was incubated for 1 h at room temperature with a specific secondary 
antibody conjugated with horseradish peroxidase at a dilution of 1:5000 ( Sc 4 200 , Santa 
Cruz Biotechnology ) and the band corresponding to Cx39 was displayed with reagents 
chemo luminescent ( ECL, GE Healthcare, formerly Amersham, Europe GmbH Branch - 
Italian , Milan, Italy ) . The ECL films were developed in Kodak D19 developer and fixed 
(Eastman - Kodak , Rochester, NY, USA) , and densitometric evaluation of the bands was 
carried out through the measurement of the optical density ( OD ) using the NIH ImageJ 
software and the results are were expressed as arbitrary units. 
 
 
Histomorphological analysis 
Longitudinal sections of 10μm of gastrocnemius and quadriceps were cut at -20 ° C and 
adherent on glass slides coated with 3-aminopropyl etossisilano. Sections of frozen muscle 
were directly fixed in 4% paraformaldehyde and stained with hematoxylin-eosin. Were finally 
dehydrated with ethanol, cleared in xylene and mounted with Entellan (Merck, Darmstadt, 
Germany) to be examined under the optical microscope. 
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Statistical Analysis 
The results were reported as mean ± SE. The analysis of variance (ANOVA) and Fisher's 
PLDS correction for post hoc comparison was used to test the difference between the wild 
type animals sedentary, wild type trained, dystrophic dystrophic sedentary and trained, both 
for the mice that for rats at different time points. The trend over time for each group was 
assessed with the paired t-test (Statview 5.0.1, SAS Institute, Inc., Cary, NC). The data was 
considered significant for values of p <0.05. 
 
Proteomic Analysis 
Protein extraction from biopsies. 
The extraction was carried out at 4 ° C in an ice bath. The tissue fragments were mechanically 
homogenized with the Politron in 50 mM Tris / HCl pH 7.5 with antibiotics (0.003% and 
0.005% Penicillin Streptomycin), put to stir over-night at 4 ° C, and centrifuged twice at 
10000 rpm for 20 min. The supernatant, containing the tissue protein, has been put to dialyse 
against millipore water at 4 ° C for 48 hours in several changes. Subsequently, the lysate was 
freeze-dried, resuspended in ISOT (8 M Urea, 4% CHAPS, 65 mM DTE and 40 mM Tris) 
and subjected to quantitative assessment of protein content. 
 
 
Two-dimensional electrophoresis 2D-IPG 
The protein extract was analyzed using isoelectric focusing in immobilized pH gradient (A. 
Gorg et al., 1988; Byellqvist B. et al., 1993). The isoelectric focusing was performed on strips 
ready, produced by Pharmacia, dehydrated and stored at -20 ° C, with non-linear gradient, 
from 4 to 10 with an expansion in the region between 5 and 7. The strips, 3 mm wide, 180 
mm long and 0.5 mm thick, were rehydrated individually for 1 hour in a solution containing 8 
M Urea, 4% CHAPS (3 - (3-cholamidopropyl dimethylamino) 1 - propane-sulfonate) , 1% 
DTE, 0.5% Resolite (anfoline pH 3.5-10) and traces of bromophenol blue 0.5%. To this 
solution was added an aliquot of the extract containing 45 micrograms of tissue protein, for a 
total volume of 350 μl. 
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The run was performed at 20 ° C , with a voltage which increases linearly from 200 to 3500 V 
during the first 4.5 hours and then stabilized at 8000 V for 8 hours. At the end of the 
electrophoretic run the strips were equilibrated in a solution consisting of 6 M Urea, 30 % 
glycerol , 2 % SDS , 0.05 M Tris / HCl pH 6.8 , 2 % DTE , for 12 min. , And then in the same 
buffer solution , replacing the 2 % DTE with 2.5% of iodoacetamide . The second dimension 
was carried out on polyacrylamide gel with a gradient of 9-16 % , with dimensions 18 x 20 
cm and a thickness of 1.5 mm . The strips were made balanced slip between the glass 
containing the gel of the second dimension, using a hot solution of 0.5 % agarose dissolved in 
buffer scroll in order to establish a continuity between the gel : the agarose , in fact , cooling 
solidifies , making the strip stay in the right position . The buffer scroll is made from 0.125 M 
Tris, 0.96 M glycine and 0.5 M SDS . The run was performed with a constant current of 20 
mA per gel , until the arrival of the reference dye at the lower edge of the gel. 
Silver staining 
The silver staining is the most sensitive staining method (about 1 ng of protein per spot) 
among those not radioactive. It is based on the specific binding of silver ions on the proteins 
previously oxidized and the subsequent reduction of these ions to metallic silver using a citric 
acid solution containing formaldehyde. 
The gel after the run are subjected to the following steps: 
 Washing with milliQ H2O for 5 min.; 
 fixing in a solution of Ethanol 40% - 10% glacial acetic acid for 60 min.; 
 fixing in a solution of 5% Ethanol - Glacial acetic acid 5% over-night; 
 washing the gel in milliQ H2O for 10 min.; 
 Sensitization in a solution of Glutaraldehyde 2% - Sodium acetate 0.5 M prepared 
using milliQ H2O at 4 ° C; 
 Three washes of 10 min. each with milliQ H2O at 4 ° C; 
 two washes of 30 min. each in 0.05% NDS (2.7 naftalendisolfonico acid), prepared 
using milliQ H2O at 4 ° C; 
 4 washes of 15 min. each in milliQ H2O at 4 ° C; 
 staining with an ammoniacal solution of silver nitrate (AgNO3) prepared with 0.8% 
AgNO3, 1% NaOH and 1% NH3 at 32%; 
 4 washes of 4 min. each with milliQ H2O at room temperature; 
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 development with a solution of citric acid, 0.005% and 1% formaldehyde at 37% for 
about 12 min. until they are visible and distinguishable spots; 
 Stop development with a solution of acetic acid at 5%. 
 
Each operation must be carried out under gentle agitation 
 
Computer analysis of the gels 
The gels stained with silver nitrate were imported into a scanner, and subsequently 
subjected to computer analysis using the computer system IMAGE MASTER 2D 
PLATINIUM that is constituted by a set of algorithms, which allow to make both 
qualitative and quantitative analysis of the gels. 
The first step in the analysis of the gel is computed to eliminate the artifacts dependent 
scanning process (shadows and bubbles are considered by the software as protein 
spots). Once you correct the image, the computer system defines the protein spots and 
their position in the image. Next, using as internal standards some "anchors", ie 
proteins with known pI and PM (eg. Plasma proteins), it was possible to calibrate the 
gel in order to convert the spatial coordinates of each spot in the respective values of 
pI and PM. 
For comparison (gel "matching") More images electrophoretic software uses special 
algorithms to match the shape and position of the spots present on different gels. 
This automatic action can be difficult in case of changes in migration between gels, 
and for this reason it is preferable to pair manually some reference spot, which serve 
as the starting point for the "matching". For a correct pairing enough about 10/15 
anchors distributed over the entire surface of the gel. 
The quantitative analysis was carried out, always with the aid of the software, 
considering the volume percentage (% Vol) of each spot, calculated by comparing the 
volume of each single stain to the sum of the volumes of all peptides present in the 
map to limit the possible differences due to a different silver staining between gels. 
The volume of each spot is calculated from the integration of the OD on its area. 
 
 
Dott.ssa Rossella Prestigiacomo Pag. 34 
 
 
 
 
 
 
RESULTS 
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FIRST AIM 
Effects of the exercise of "endurance" low intensity on regeneration in the gastrocnemius 
muscle of rat subjected to mechanical damage 
The rats were divided into four experimental groups: sedentary control, control train them, 
crush sedentary and trained. As shown in Table II, the trained rats were subjected to a 
workout for nine days until it reaches the desired exercise regime; ninth day was carried out 
the mechanical crush of the gastrocnemius muscle as described in materials and methods. 
After crush the workout was continued for another 7 days and 24 h after the last training 
session the rats were sacrificed to assess the levels of Cx39 in the trained compared to control 
lesioned but not trained. 
 
 
 
 
 
 
Table II 
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Recovery of skeletal tissue damaged by mechanical trauma in rats 
Histomorphological analysis  
The histological analysis of sections of gastrocnemius  muscle tissue was performed in order 
to evaluate the effects of an exercise of "endurance" low intensity on the progression of 
regeneration process in rats with mechanicl trauma. The sections of muscle tissue were 
stained using hematoxylin –esoin method and they reveals a visible reduction of the necrosis 
area and an upgrade of the regenerating part in the muscle section coming from the trained rat. 
 
 
 
 
Fig. 9: Section of quadriceps muscle of 
sedentary rats. 
Fig. 10: Section of quadriceps muscle of 
trained rat 
 
The Graph shows the reduction of the face of 
the regeneration. The reduction in the trained 
animals is the 23% compared to the cntrl 
animals. 
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Determination of the levels of Cx39 as a marker for assessing the degree of regeneration of 
the damaged muscle 
 
In a previous work (Trovato-Salinaro et al., 2009) we demonstrated that Cx39 appears to be 
expressed exclusively in skeletal muscle tissue during embryonic development and one week 
after birth declines until it disappears, therefore, turns out to be not expressed in adult muscle. 
Such embryonic expression of Cx39 is involved in the aggregation and fusion of myogenic 
cells for the formation of myotubes and then miofibre muscle (Belluardo et al., 2005). As in 
adult skeletal muscle, different types of trauma promote the proliferation of satellite cells that 
differentiate into myoblasts to form new myofibers or repair the damaged myofibers, 
recapping the sequences of the embryonic processes, we hypothesized that the Cx39 could be 
re-expressed in the training phase of new myotubes regenerating. 
In the figure below, the graph shows the results obtained by the western blotting analysis for 
the gastrocnemius muscle. Muscle control that does not have therefore suffered mechanical 
damage, Cx39 is absent. The presence of cx39 is also absent in the muscle of rats subjected to 
training. The expression of cx 39 is present and is elevated in the muscle of rats with 
mechanical muscle damage not trained. As we can see from the analysis of wb, in the muscle 
of rats trained with mechanical muscle damage, there is a reduction of cx39 expression. This 
reduction means that endurance training leads to an acceleration of the process of muscle 
regeneration and damage repair muscle. Altogether this model confirms that, during muscle 
regeneration following the crush, there is a transient activation of Cx39 in the damaged area 
and its expression testifies an active regenerat process (Belluardo et al., 2005). 
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Fig.9: Western Blotting analysis of the levels of the Cx 39 expression in rat’s 
muscle with mechanical damage and subjected to training. The western blotting 
analysis shows that in rat not trained  with crush there’s an elevated expression 
of the Cx39 compared with rats with crush undergo training. 
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SECOND AIM 
Rating proteomic pattern of protein expression in wild type mice, mdx sedentary mdx 
trained mice to identify some important proteins involved in skeletal muscle regeneration. 
 
Were identified 73 spots corresponding to 31 different proteins indicated in the underlying 
reference map by their respective code of access to the bank UNICOD. 
 
 
 
 
 
It was also created a table in which each protein identified was associated: 
Fig.11.: Proteomic map of quadriceps and protein spots identified 
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 abbreviated name,  
 number of access to the database,  
 experimental pI and pM,  
 mascot score, which is an index of statistical significance used in mass 
spectrometry,  
 peptides identified,  
 sequence scorage,  
 identification technique, or gel matching with reference maps in specific 
databases, rather than peptide mass finger printing or mass-mass. 
 
Nome 
Proteina 
 
Nome 
abbreviat
o 
 
Numero di 
accesso 
(Swiss-Prot) 
(a) 
 
pI – MW 
(kDa) 
speriment
ali (b) 
 
Mascot 
score 
(c) 
 
Peptidi 
identific
ati (d) 
 
Sequence 
coverage 
% (e) 
 
Tecnica di 
identificazio
ne 
Phosphoglycerate mutase 2 PGAM2 O70250 8,55 – 28208    GM
(f) 
Hemoglobin subunit beta-1 HBB1 P02088 7,20 – 11731 87 9 53 
PMF(g)/MS-
MS(h) 
Hemoglobin subunit beta-
1/Hemoglobin subunit alpha  
HBB1/HB
A 
P02088/P019
42 
6,75 – 
11852 48 6  
PMF/MS-
MS 
Hemoglobin subunit beta-
1/Hemoglobin subunit alpha 
P02088/P019
42 
8,21 – 
11770 25 - 26 3 – 4 25 – 50 
GM - 
PMF/MS-
MS 
Myoglobin MYG P04247 7,13 – 13885    GM 
Fructose-bisphosphate aldolase A  
ALDOA 
P05064 8,03 – 39728 209 16 59 GM – PMF 
Fructose-bisphosphate aldolase A P05064 7,33 – 40001 185 14 64 GM – PMF 
Myosin light chain 1/3, skeletal 
muscle isoform 
 
 
 
MYL1 
P05977 4,50 – 12511    GM 
Myosin light chain 1/3, skeletal 
muscle isoform P05977 
4,50 – 
13044    GM 
Myosin light chain 1/3, skeletal 
muscle isoform P05977 
4,96 – 
23410    GM 
Myosin light chain 1/3, skeletal 
muscle isoform P05977 
5,04 – 
23161    GM 
Creatine kinase M-type 
 
 
 
 
 
 
KCRM 
P07310 6,64 – 30091 92 9 28 PMF 
Creatine kinase M-type P07310 6,56 – 40985 142 12 44 GM – PMF 
Creatine kinase M-type P07310 6,46 – 40532    GM 
Creatine kinase M-type P07310 6,74 – 40352 158 13 43 
GM - 
PMF/MS-
MS 
Creatine kinase M-type P07310 6,65 – 40532 69 6 21 
GM 
PMF/MS-
MS 
Creatine kinaseM-type P07310 6,74 – 49922    MS-MS 
Creatine kinase M-type P07310 6,47 – 25176 73 9 27 MS-MS 
Albumin 
 
 
ALBU 
P07724 5,35 – 66368    GM 
Albumin P07724 5,41 – 66000    GM 
Albumin P07724 5,35 – 66368    GM 
Superoxide dismutase [Cu-Zn] SODC P08228 6,10 – 14597 82 5 31 PMF 
Cytochrome c oxidase subunit 5A, COX5A P12787 5,12 –    GM 
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mitochondrial 10453 
Carbonic anhydrase 3 
 
 
CAH3 
P16015 6,74 – 27613    GM 
Carbonic anhydrase 3 P16015 6,82 – 27782 78 7 48 PMF 
Carbonic anhydrase 3 P16015 6,72 – 28122    
GM - MS-
MS 
Glyceraldehyde-3-phosphate 
dehydrogenase G3P P16858 
8,32 – 
35785    GM 
Alpha-enolase  
ENOA 
P17182 6,25 – 46511    GM 
Alpha-enolase P17182 6,01 – 46256    GM 
Triosephosphate isomerase 
 
 
 
 
 
TPIS 
P17751 6,59 – 25605    GM 
Triosephosphate isomerase P17751 6,48 – 25667    GM 
Triosephosphate isomerase P17751 6,74 – 25667    GM 
Triosephosphate isomerase P17751 6,71 – 25636    GM 
Triosephosphate isomerase P17751 6,75 – 25824    GM 
Triosephosphate isomerase P17751 7,44 – 25636    GM 
 
Beta-enolase  
 
ENOB 
P21550 6,52 - 45750 68 9 20 GM – PMF 
Beta-enolase P21550 6,68 - 45750    GM – PMF 
Beta-enolase P21550 6,35 - 45834    GM 
Protein S100-A8 S100A8 P27005 5,14 - 10780 56 4 73 PMF 
Acyl-CoA-binding protein ACBP P31786 8,63 - 12492 35 3 45 PMF/MS-
MS 
Parvalbumin alpha  
PRVA 
P32848 4,96 - 12745 130 21 72 PMF 
Parvalbumin alpha P32848 4,84 - 12935 63 6 27 GM - 
PMF/MS-
MS 
Pyruvate kinase M  
 
PKYM 
P52480 6,74 - 55064    GM 
Pyruvate kinase M P52480 6,73 - 55686    GM 
Pyruvate kinase M P52480 6,71 - 55064    GM 
ATP synthase subunit beta, 
mitochondrial 
ATBP P56480 2,02 - 47809    GM 
Tropomyosin alpha-1 chain TPM1 P58771 4,87 - 33929    GM 
Tropomyosin beta chain TPM2 P58774 4,70 - 36327 89 16 33 PMF 
Actin, cytoplasmic 1  
 
 
 
ACTB 
P60710 5,27 - 42937    GM 
Actin, cytoplasmic 1 P60710 5,13 - 43175    GM 
Actin, cytoplasmic 1 P60710 5,06 - 43414    GM 
Actin, cytoplasmic 1 P60710 5,19 - 43725    GM 
Actin, cytoplasmic 1 P60710 5,09 - 41351    GM 
Actin, alpha skeletal muscle  
ACTS 
P68134 5,27 - 45208    GM 
Actin, alpha skeletal muscle P68134 5,49 - 41254 69 6 19 PMF 
Myosin regulatory light chain 2, 
skeletal muscle isoform 
 
 
 
 
 
 
 
MLRS 
P97457 5,23 - 26867 76 7 39 PMF 
Myosin regulatory light chain 2, 
skeletal muscle isoform 
P97457 4,77 - 14843    GM 
Myosin regulatory light chain 2, 
skeletal muscle isoform 
P97457 4,68 - 14967    GM 
Myosin regulatory light chain 2, 
skeletal muscle isoform 
P97457 4,78 – 15834 177  79 GM – PMF 
Myosin regulatory light chain 2, 
skeletal muscle isoform 
P97457 4,68 – 15900 106  68 GM – PMF 
Myosin regulatory light chain 2, 
skeletal muscle isoform 
P97457 4,78 – 17488 199 17 78 GM – PMF 
Myosin regulatory light chain 2, 
skeletal muscle isoform 
P97457 4,78 – 17488 189 18 79 GM – PMF 
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Myosin-6 MYH6 Q02566 5,27 –141926    GM 
Myosin-4  
 
 
MYH4 
Q5SX39 5,40 – 49357 119 25 11 PMF 
Myosin-4 Q5SX39 5,44 – 56950    PMF 
Myosin-4 Q5SX39 5,37 – 59155    PMF 
Myosin-4 Q5SX39 5,41 – 74312 56 15 11 PMF/MS-
MS 
Creatine kinase S-type, 
mitochondrial 
 
KCRS 
Q6P8J7 7,18 – 41949    GM 
Creatine kinase S-type, 
mitochondrial 
Q6P8J7 7,02 – 42276    GM 
Troponin T, fast skeletal muscle  
TNNT3 
Q9QZ47 8,65 – 33679    PMF/MS-
MS 
Troponin T, fast skeletal muscle Q9QZ47 8,56 – 33679 75 8 26 PMF/MS-
MS 
Adenylate kinase isoenzyme 1  
KAD1 
Q9R0Y5 5,33 – 24292 88 9 51 PMF 
Adenylate kinase isoenzyme 1 Q9R0Y5 5,33 – 23720 100 10 48 PMF 
 
 
In order to have a functional enhancement of the identified proteins, we wanted to make a 
subdivision of the same, according to the three criteria of the Gene Ontology: cellular 
components, molecular functions, biological processes. 
Thanks to this analysis was possible to ascertain that 82% are cellular proteins, most of which 
has both cellular functions that enzymatic functions and another part of them is involved in 
metabolic processes. 
 
 
 
 
Table 3. : Table that shows the 31 proteins identified in the reference proteomic quadriceps map. 
Dott.ssa Rossella Prestigiacomo Pag. 43 
 
 
 
 
 
 
 
 
 
Fig.12,13 and 14 : Graphs obtained from the analysis carried out by 
Gene Onthology 
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This type of analysis was further confirmed by analysis of the classes of the system panther 
protein, which indicates that most of the protein has a role purely enzymatic and structural. 
 
 
 
 
 
 
 
 
 
 
 
Fig.15: Protein classes panther system 
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Comparative Analysis 
It was conducted comparative analysis of 2D gel scanned using analytical software 
bioinformatics, in this case Image Master 2D platinum. This software allows you to perform 
quantitative analyzes related to different proteomic profiles. Were made two types of 
comparison: 
 proteomic profile of wild type mice versus mdx not trained mice; 
 proteomic profile of mdx trained mice versus mdx not trained mice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
WT MDX sed 
VS 
MDX ex MDX sed 
VS 
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The software, in order to make on quantitative analysis, using as a parameter the volume 
percentage. This volume is obtained from the volume of a given spot, divided by the 
summation of all the volumes in a specific map for 100. This calculation was performed in 
order to have a more normalized data possible and make accurate analysis. 
 
Experimental replicates 
In order to perform accurate analysis of proteomics is strictly necessary to follow a precise 
experimental design: it was performed a minimum of three experimental replicates  each 
condition examined, from which it is evidenced that there was no significant difference.  
Therefore, the study was based on a minimum of three independent replicates for each 
condition tested: wild type mice, mdx mice trained and not trained mdx mice. The parameter 
used for the analysis of the maps was the volume percentage, obtained from an average of at 
least three independent experimental replicates for each sample.  
 
P-cluster analysis 
To have a global view of changes in the pattern of protein expression of the three conditions 
examined, hierarchical cluster analysis was performed by the use of specific algorithms such 
as p-cluster analysis. From this analysis it was possible to observe that the two proteomic 
profiles of mdx mice are more similar to each other than the proteomic profile of the wild-
type mice, and this has suggested that exercise does not result in a drastic change in the 
proteomic profile of the mdx.  
This global analysis is confirmed by a detailed analysis of comparative proteomic. 
 
 Fig.16: P-cluster analysis of the proteins 
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Proteomic comparison profile wild-type mice versus  mdx mice not trained 
In the comparison of the analytical maps of the quadriceps of wt mice versus mdx not trained, 
we observed 12 spots corresponding to differentially expressed proteins involved in 
carbohydrate metabolism as the triosofosfatoisomerasi, glyceraldehyde-3-phosphate 
dehydrogenase, and proteins involved in muscle contraction such as the myosin light chain, 
proteins that play a role in the mechanism regulation of oxidative stress. 
 
 
 
 
 
 
 
 
 
 
 
In the table below we show the 12 differentially expressed proteins in the two proteomes 
examined. 
Nome Proteina  
Nome 
abbreviato 
N. di 
accesso in 
Swiss-
Prot®  
pI-PM 
(kDa) 
MDX sed 
vs  
WT sed 
(a) 
t-test 
(a) 
MDX ex  
vs MDX sed (a) 
t-test 
(a) 
Carbonic anhydrase 3 CAH3 P16015 6,72 - 28122 2,8 0,046 -3,6 0,022 
Carbonic anhydrase 3 CAH3 P16015 6,74 - 27613 2,7 0,040 -2,3 0,042 
Carbonic anhydrase 3 CAH3 P16015 6,82 - 27782 2,1 0,033 -1,7 0,039 
Cytochrome c oxidase 
subunit 5A, mitochondrial COX5A P12787 5,12 - 10453 -2,5 0,047   
Glyceraldehyde-3-
phosphate dehydrogenase G3P P16858 8,32 - 35785 1,7 0,034   
Myosin regulatory light 
chain 2, skeletal muscle 
isoform 
 
MLRS P97457 4,78 - 15834 -7,9 0,005   
Myosin 4 MYH4 Q5SX39 5,37 - 59155 -4,3 0,027   
WT MDX not trained 
Fig.17 and 18: Proteomic maps of the two proteomes examined: wild tipe mice and dystrophic 
mice. 
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Myosin light chain 1/3, 
skeletal muscle isoform MYL1 P05977 4,50 - 13044 -4,1 0,043   
Parvalbumin alpha PRVA P32848 4,84 - 12935 -4,7 0,013   
Superoxide dismutase [Cu-
Zn] SODC P08228 6,10 - 14597 -5,28 0,02 2,10 0,01 
Troponin T TNNT Q9QZ47 8,65 - 33679 -3,1 0,020   
Triosephosphate isomerase TPIS P17751 6,48 25667 1,5 0,014   
 
 
 
Proteomic comparison profile mdx trained mice versus mdx not trained mice . 
In the comparison between the maps of mdx mice trained and not trained mdx mice, we 
observed only 4 spots differentially expressed, which correspond to the three isoforms of 
carbonic anhydrase and superoxide dismutase-c. This is of particular biological significance 
because the semi-quantitative differences observed between mdx mdx mice trained and not 
trained and wild type mice, are changed back by aerobic exercise of short duration and low 
intensity. Was considered a significant change when it is obtained a variation of at least 1, 5 
times and a p-value ≤0.05. 
 
Nome Proteina  
Nome 
abbreviato 
N. di 
accesso in 
Swiss-
Prot®  
pI-PM 
(kDa) 
MDX sed 
vs  
WT sed (a) 
t-test 
(a) 
MDX ex  
vs MDX sed (a) 
t-test 
(a) 
Carbonic anhydrase 3 CAH3 P16015 6,72 - 28122 2,8 0,046 -3,6 0,022 
Carbonic anhydrase 3 CAH3 P16015 6,74 - 27613 2,7 0,040 -2,3 0,042 
Carbonic anhydrase 3 CAH3 P16015 6,82 - 27782 2,1 0,033 -1,7 0,039 
Superoxide dismutase [Cu-
Zn] 
SODC P08228 6,10 - 14597 -5,28 0,02 2,10 0,01 
 
 
 
 
 
 
 
Table4: The table shows the 12 different proteins expressed in the two proteomes examined, wt mice and 
mdx not trained mice. 
Table 5: Table shows the 4 proteins differentially expressed in the two proteomes examined 
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Changes of superoxide dismutase and carbonic anhydrase-3 
Going to see the specific changes of superoxide dismutase-c, it is possible to note from the 
graph below, which are witnessing a substantial decrease in the levels of this protein 
compared to wt and in phenotype mdx trained mice. 
 
 
 
The sod-c is an enzyme with antioxidant activity involved in the regulation of oxidative stress 
and having found a decrease of that protein in dystrophic fibers not subjected to training, we 
are witnessing an increase in oxidative stress in these fibers, which is a typical characteristic 
of dystrophic muscle fibers.  
This increase in oxidative stress, may also explain the increase of the three isoforms of 
carbonic anhydrase that is we have observed in the phenotype of mdx mice not trained. 
Fig.19 : The graph shows the different expression of the SODC protein in the three proteomes 
examined. The protein is highly expressed in the phenotype wt, decreases in the phenotype of mdx 
mice not trained, but it is very expressed in the mdx phenotype trained. 
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The carbonic anhydrase 3 are metallo-enzymes involved in biological processes and has been 
shown to have a role in the regulation of oxidative stress. In the literature, in some work, has 
been shown that there is a correlation directly proportional between increase in oxidative 
stress in the dystrophic fibers and increased levels of CAH3. 
In the context of innovative therapies such as antioxidant therapies, has been shown that by 
using specific inhibitors such as those for CAH3 precisely in mdx mice, we are witnessing a 
decrease of the areas of necrosis and a functional recovery of the muscle itself. 
 
 
 
 
 
 
 
Fig 20: The graph shows the different expression of the CAH3 protein in the three proteomes examined. 
The protein is very expressed in the phenotype mdx not trained. 
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Recovery of damaged skeletal muscle following low-intensity endurance 
exercise and proteomics analysis 
 
Based on an previous study conducted in our laboratory, (Frinchi et al 2013) in which it is 
shown that an appropriate training program of short duration and low intensity leads to an 
acceleration in the process of muscle regeneration in dystrophic mice, we wanted to 
investigate the possibility that the 'training, could perform the same role in an experimental 
model that is not present muscle damage related to a disease, but rather, to a muscle trauma of 
mechanical origin. 
To conduct our study, were used rats to which was produced traumatic muscle damage and 
were subsequently subjected to a period of endurance training. To evaluate the process of 
muscle regeneration from training accelerated endurance were evaluated expression levels of 
CX39 (Belluardo 2005) as a marker of tissue regeneration. The study conducted shows that 
the levels of this protein, expressed in the early stages of embryonic life and after muscle 
damage, tend to be lower in rats with crush undergo training compared with rats with crush 
not undergo training.  
The fact that the levels of CX39 are lower in rats with crush undergoing training, indicates 
that in muscle take place healing process favored by training. Concerning the mechanisms 
involved in this recovery of muscle damage, we may examine several possibilities. 
 Endurance training produces many physiological, metabolic and vascular adaptations in 
skeletal muscle but it is not clear how these changes may improve muscle damage . Low- 
intensity endurance may have anti-inflammatory  action that can prevent or reduce muscle 
degeneration process in rats as has seen in a previous study in mdx mice. More likely, several 
factors released in response to endurance exercise may regulate muscle stem cells and 
therefore enhance the adaptive response of skeletal muscle. 
Discussion 
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Based on the results obtained from experiments on rats, we wondered what were the 
molecular mechanisms that underlie this process of accelerated muscle regeneration from 
training endurance. So we conducted a proteomics analysis in order to have a window open 
on muscle cells at a particular time in their lives.  
To make the proteomic analysis, we used the mdx mice as an experimental model, previously 
studied in our laboratory.(Frinchi et al). 
 The mdx mice were divided into three experimental groups, wt Mdx, Mdx trained and not 
trained Mdx. Of these animals, we have built the proteome reference map of the quadriceps 
muscle. This map was not yet present in the literature.  
The map identified 73 protein spots corresponding to 31 proteins. Once obtained the reference 
map was possible to conduct comparative proteomic analysis, comparing the three different 
proteomes. From this analysis it was found that in the three proteomes varies very expression 
of proteins involved in the mechanism of oxidative stress. 
From this analysis it was found that in the three proteomes varies very expression of proteins 
involved in the mechanism of oxidative stress. In particular vary four proteins, namely, the 
three isoforms of carbonic anhydrase and superoxide dismutase-c. 
Looking specifically Sod-c, from the analysis we have seen a decrease in the levels of this 
protein in the mdx phenotype not trained. Instead, this protein is highly expressed in the 
phenotype of mdx be trained. As we have seen, the Sod-c is a metal- enzyme with antioxidant 
activity involved in the regulation of oxidative stress. A decrease in the levels of expression of 
this protein in the fibers dystrophic untrained, involves an increase in oxidative stress in these 
fibers. 
Such an increase in oxidative stress may also explain the increased expression of the three 
isoforms of carbonic anhydrase, which, as shown by the analysis conducted, it is observed in 
the mdx phenotype not trained. The analysis shows that there are obvious differences 
compared to the wt phenotype, the phenotype mdx trained is closer to the phenotype wt.  
In some studies in the literature, it has been demonstrated that there is a directly proportional 
correlation between increased oxidative stress in these fibers and increase of carbonic 
anhydrase-3. In the literature in the context of innovative therapies, therapies such as 
antioxidants, it has been shown that by using specific inhibitors such as those for CAH3 in 
mdx mice is witnessing a decrease of the areas of necrosis. So, not only pharmacologically 
but also as we have shown exercise, contributes to functional recovery of the muscle. 
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